Procalcitonin for the differential diagnosis of infectious and non-infectious systemic inflammatory response syndrome after cardiac surgery

Journal of Intensive Care

Volumn 2, Issue 1, 2014, Pages

  Zhao, Dong ^a,c   Zhou, Jianxin ^b   Haraguchi, Go ^c   Arai, Hirokuni ^c   Mitaka, Chieko ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

C reactive protein; Cardiac surgery; Infection; Procalcitonin; Systemic inflammatory response syndrome

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BRAIN HEMORRHAGE; CANDIDIASIS; CONTINUOUS RENAL REPLACEMENT THERAPY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; EXTRACORPOREAL OXYGENATION; FEMALE; HEART SURGERY; INFECTION; INFLAMMATION; LENGTH OF STAY; LEUKOCYTE COUNT; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; NON INFECTIOUS SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SURGICAL MORTALITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84979198061     PISSN: None     EISSN: 20520492     Source Type: Journal    
DOI: 10.1186/2052-0492-2-35     Document Type: Article

References (24)

1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554. 10.1056/NEJMoa022139, 12700374.
2. Agnus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310. 10.1097/00003246-200107000-00002, 11445675.
3. Kerbaul F, Guidon C, Lejeune PJ, Mollo M, Mesana T, Gouin F. Hyperprocalcitonemia is related to noninfectious postoperative severe systemic inflammatory response syndrome associated with cardiovascular dysfunction after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2002, 16:47-53. 10.1053/jcan.2002.29672, 11854878.
4. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596. 10.1097/01.CCM.0000217961.75225.E9, 16625125.
5. Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003, 31:1737-1741. 10.1097/01.CCM.0000063440.19188.ED, 12794413.
6. Jebali MA, Hausfater P, Abbes Z, Aouni Z, Riou B, Ferjani M. Assessment of the accuracy of procalcitonin to diagnose postoperative infection after cardiac surgery. Anesthesiology 2007, 107:232-238. 10.1097/01.anes.0000271871.07395.ad, 17667566.
7. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41:580-637. 10.1097/CCM.0b013e31827e83af, 23353941.
8. Taylor FB, Toh CH, Hoots WK, Wada H, Levi M. Scientific subcommittee on disseminated intravascular coagulation (DIC) of the international society on thrombosis and haemostasis (ISTH): towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001, 86:1327-1330.
9. Müller B, White JC, Nylén ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001, 86:396-404.
10. Polomsky M, Puskas JD. Off-pump coronary artery bypass grafting-the current state. Circ J 2012, 76:784-970. 10.1253/circj.CJ-12-0111, 22451446.
11. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J, . Geneva Sepsis Network Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001, 164:396-402. 10.1164/ajrccm.164.3.2009052, 11500339, Geneva Sepsis Network.
12. Du B, Pan J, Chen D, Li Y. Serum procalcitonin and interleukin-6 levels may help to differentiate systemic inflammatory response of infectious and non-infectious origin. Chin Med J (Engl) 2003, 116:538-542.
13. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004, 39:206-217. 10.1086/421997, 15307030.
14. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006, 34:1996-2003. 10.1097/01.CCM.0000226413.54364.36, 16715031.
15. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007, 7:210-217. 10.1016/S1473-3099(07)70052-X, 17317602.
16. Contou D, D'Ythurbide G, Messika J, Ridel C, Parrot A, Djibré M, Hertig A, Rondeau E, Fartoukh M. Description and predictive factors of infection in patients with chronic kidney disease admitted to the critical care unit. J Infect 2014, 68:105-115. 10.1016/j.jinf.2013.10.003, 24140065.
17. Meisner M, Hüttemann E, Lohs T, Kasakov L, Reihart K. Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients. Shock 2001, 15:171-175. 10.1097/00024382-200115030-00002, 11236898.
18. Rungatscher A, Merlini A, De Rita F, Lucchese G, Barozzi L, Faggian G, Mazzucco A, Lucuani GB. Diagnosis of infection in paediatric veno-arterial cardiac extracorporeal membrane oxygenation: role of procalcitonin and C-reactive protein. Eur J Cardiothorac Surg 2013, 43:1043-1049. 10.1093/ejcts/ezs524, 23026736.
19. Clec'h C, Fosse JP, Karoubi P, Vincent F, Chouahi I, Hamza L, Cupa M, Cohen Y. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006, 34:102-107. 10.1097/01.CCM.0000195012.54682.F3, 16374163.
20. Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schüttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998, 24:680-684. 10.1007/s001340050644, 9722037.
21. Ugarte H, Silva E, Mercan D, De Mendonça A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999, 27:498-504. 10.1097/00003246-199903000-00024, 10199528.
22. Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 2000, 26(Suppl 2):S148-S152.
23. Rahmanian PB, Kröner A, Langebartels G, Ozel O, Wippermann J, Wahlers T. Impact of major non-cardiac complications on outcome following cardiac surgery procedures: logistic regression analysis in a very recent patient cohort. Interact Cardiovasc Thorac Surg 2013, 17:319-327. 10.1093/icvts/ivt149, 23667066.
24. Chen LF, Arduino JM, Sheng S, Muhlbaier LH, Kanafani ZA, Harris AD, Fraser TG, Allen K, Corey GR, Fowler VG. Epidemiology and outcome of major postoperative infections following cardiac surgery: risk factors and impact of pathogen type. Am J Infect Control 2012, 40:963-968. 10.1016/j.ajic.2012.01.012, 3535474, 22609237.